Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Revenue | 1.76B | 1.2% |
| Gross Profit | 159M | 11.8% |
| Cost of Revenue | 1.6B | 0.3% |
| Operating expense | 104M | 0.4% |
| Net Income | 78M | 20% |
| EBITDA | 212M | 11.1% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 7.88B | 0.2% |
| Total Liabilities | 6.14B | 0.9% |
| Total Equity | 1.42B | 3.6% |
| Shares Outstanding | 130M | 1.3% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | 278M | 517.1% |
| Cash from investing | -54M | 6.2% |
| Cash from financing | -206M | 254.6% |
EPS
Financial Highlights for Select Medical in Q2 '24
Select Medical reported a revenue of 1.76B, which is a 1.2% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 159M, marking a 11.8% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 1.6B, a 0.3% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 104M, showing a 0.4% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 78M, showing a -20% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 212M, showing a -11.1% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Select Medical faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
